-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Combining Antiplatelet and Anticoagulant Therapy in Cardiovascular Disease

Program: Education Program
Session: What Hematologists Need to Know About Giving and Stopping Aspirin
Hematology Disease Topics & Pathways:
anticoagulant drugs, Non-Biological, Therapies, Quality Improvement
Monday, December 7, 2020, 6:55 AM-7:00 AM

Geoffrey D. Barnes, MD, MSc

Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI

Disclosures: Barnes: Janssen: Consultancy; Portola: Consultancy; Pfizer/Bristol-Myers Squibb: Consultancy, Research Funding; Anticoagulation Forum: Membership on an entity's Board of Directors or advisory committees; National Certification Board of Anticoagulation Providers: Membership on an entity's Board of Directors or advisory committees; AMAG Pharmaceuticals: Consultancy.

See more of: What Hematologists Need to Know About Giving and Stopping Aspirin
See more of: Education Program
<< Previous Presentation | Next Presentation >>